First Trust Nasdaq Pharmaceuticals ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 34.60
成立日期: 20/09/2016
 
分析
市值分佈:
87.79%
大市值
0.79%
中市值
--
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 42  
0%
 
100%
     10大 (56.80%)
代號 名稱 佔比% 持有日期
AMRXAmneal Pharmaceuticals0.7826/02/2026
HALOHalozyme Therapeutics0.7626/02/2026
ALKSAlkermes plc0.7526/02/2026
IONSIonis Pharmaceuticals0.7426/02/2026
KRYSKrystal Biotech0.7426/02/2026
PTGXProtagonist Therapeutics0.5926/02/2026
NBIXNeurocrine Biosciences0.5926/02/2026
GHGuardant Health0.5726/02/2026
NAMSNewAmsterdam Pharma Company NV0.5626/02/2026
BBIOBridgeBio Pharma0.5126/02/2026
MIRMMirum Pharmaceuticals0.4926/02/2026
CPRXCatalyst Pharmaceuticals0.4926/02/2026
SUPNSupernus Pharmaceuticals0.4926/02/2026
LGNDLigand Pharmaceuticals0.4826/02/2026
PBHPrestige Consumer Healthcare0.4326/02/2026
TGTXTG Therapeutics0.4126/02/2026
RYTMRhythm Pharmaceuticals0.3726/02/2026
ACADACADIA Pharmaceuticals0.3726/02/2026
ADMAADMA Biologics0.3526/02/2026
PRGOPerrigo Company PLC0.3126/02/2026
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.